Learning objectives: Recognize OUD as chronic, remitting-recurring neurobehavioral disorder.
Explain the rationale for medication treatment and its effectiveness in reducing overdose mortality.
Tuesday, October 23, 2018 - 12:00pm to 1:00pm
Peter D. Friedmann, MD, MPH, FASAM, FACP
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation